Walleye Capital
AUTL

Walleye Capital’s Autolus Therapeutics AUTL Stock Holding History

Walleye Capital’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-75,940
Closed -$178K – 4241
2024
Q4 		$178K Sell
75,940
-986,453
-93% -$3.33M ﹤0.01% 3843
2024
Q3 		$3.86M Sell
1,062,393
-126,100
-11% -$503K 0.01% 1366
2024
Q2 		$4.14M Buy
1,188,493
+359,732
+43% +$1.55M 0.01% 1436
2024
Q1 		$5.29M Sell
828,761
-21,390
-3% -$133K 0.01% 1247
2023
Q4 		$5.47M Buy
+850,151
New +$3.24M 0.01% 1044
2019
Q3 		– Sell
-10,431
Closed -$168K – 1896
2019
Q2 		$168K Buy
+10,431
New +$233K 0.02% 1035

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return